Sponsor Check › Person
Related person on Form D filings · address states as listed: NJ, CA, WA, MA, GA · listed Mar 17, 2010 → Feb 13, 2024
Data last updated: Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 23, 2026, 11:57 PM ET · SEC enforcement last checked: not yet
Privacy: business-related public information only. Residential addresses are never shown; only the state from the filing.
The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.
None found in sources searched.
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30) — federal district + bankruptcy courts; live RECAP re-check pending. State courts: not yet searched. PACER: not searched. · Last checked Oct 23, 2026, 11:57 PM ET.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.
Not yet searched.
Search queued. Results are added automatically; check back later or follow this page to be notified.
None found in sources searched.
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Last checked Oct 23, 2026, 11:57 PM ET.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
Comparisons are made for sponsors and sponsor groups, not individual people.
1 of 31 offerings reports sales commissions totalling $232,500; 0 report finder's fees; 0 report proceeds to related persons. (includes amounts the issuer reported as estimates)
| Source | Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it |
|---|---|---|---|---|---|
| EDGAR ↗ | Feb 13, 2024 D File 021-505161 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 13, 2021 D File 021-386253 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | May 8, 2020 D File 021-366580 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | May 8, 2020 D File 021-366581 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 29, 2018 D File 021-315844 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 5, 2018 D File 021-302491 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 18, 2016 D File 021-274816 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 20, 2015 D File 021-249771 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Apr 17, 2015 D File 021-238181 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 24, 2013 D File 021-200199 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | May 8, 2013 D File 021-196141 | $0 | $0 | $0 (est.) The general partner or an affiliate thereof will receive a management fee payable by FH VII. | None listed on this filing |
| EDGAR ↗ | Mar 22, 2013 D File 021-193796 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 25, 2013 D File 021-190823 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 13, 2012 D File 021-188300 | $232,500 | $0 | $0 | Trump Securities, LLC BrokerCheck CRD 47107 ↗ |
| EDGAR ↗ | Oct 3, 2012 D File 021-184931 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Aug 10, 2012 D File 021-182573 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 3, 2012 D File 021-180706 | $0 | $0 | $0 (est.) An affiliate of the General Partner will receive an investment advisory fee payable by the Issuer quarterly in advance. The investment advisory fee will generally be equal to a percentage of commitments as specified in the Issuer's constituent agreement. | None listed on this filing |
| EDGAR ↗ | Jun 21, 2012 D/A File 021-180127 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 17, 2012 D File 021-171945 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 22, 2011 D File 021-170556 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 5, 2011 D/A File 021-160894 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Sep 26, 2011 D File 021-166341 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 11, 2011 D File 021-162630 | $0 | $0 | $0 Funds to be used for working capital | None listed on this filing |
| EDGAR ↗ | Feb 1, 2011 D File 021-154689 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 21, 2010 D File 021-152280 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Sep 23, 2010 D File 021-148086 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Aug 11, 2010 D File 021-146233 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Apr 19, 2010 D File 021-140790 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 17, 2010 D File 021-117069 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 12, 2010 D File 021-82434 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | May 27, 2009 D/A File 021-118709 | $0 | $0 | $0 | None listed on this filing |
As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across every filing this person is listed on (latest filing per offering, per issuer).
| Source | Issuer | Role | Filed | Form | Offering | Sold | Investors | Min. investment |
|---|---|---|---|---|---|---|---|---|
| EDGAR ↗ | Tyra Biosciences, Inc. | Director | Feb 13, 2024 | D | $199,999,934 similar: $2,000,000–$19,999,994 | $199,999,934 | 21 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Affinivax, Inc. | Director | Jan 13, 2021 | D | $225,999,698 similar: $2,000,000–$19,999,994 | $225,999,698 | 27 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Vir Biotechnology, Inc. | Director | May 8, 2020 | D | $32,444,441 similar: $2,000,000–$19,999,994 | $32,444,441 | 1 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Vir Biotechnology, Inc. | Director | May 8, 2020 | D | $250,000,000 similar: $2,000,000–$19,999,994 | $250,000,000 | 1 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Vir Biotechnology, Inc. | Director | Jun 29, 2018 | D | Indefinite similar: $2,000,000–$14,000,000 | $66,000,000 | 5 similar: 1–19 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Affinivax, Inc. | Director | Jan 5, 2018 | D | $6,987,455 similar: $2,000,000–$19,999,994 | $6,987,455 | 5 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Cartiva, Inc. group: Carticept | Director | Nov 18, 2016 | D | $8,500,000 similar: $829,831–$9,999,998 | $7,000,000 | 2 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Sienna Biopharmaceuticals, Inc. | Executive Officer, Director | Oct 20, 2015 | D | $40,358,076 similar: $2,000,000–$19,999,994 | $18,466,888 | 12 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Cartiva, Inc. group: Carticept | Director | Apr 17, 2015 | D | $8,500,001 similar: $829,831–$9,999,998 | $6,000,001 | 1 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Cartiva, Inc. group: Carticept | Director | Jul 24, 2013 | D | $4,482,240 similar: $829,831–$9,999,998 | $4,312,712 | 9 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Frazier Healthcare VII-A, L.P. group: Frazier Healthcare | Executive Officer Member of the general partner of the Issuer's general partner | May 8, 2013 | D | $82,500,000 similar: $155,000–$5,250,000 | $82,500,000 | 3 similar: 4–27 | $1,000,000 similar: $1,000–$100,000 |
| EDGAR ↗ | Achaogen Inc | Director | Mar 22, 2013 | D | $30,683,703 similar: $2,000,000–$19,999,994 | $18,905,707 | 15 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | GLAUKOS Corp | Director | Jan 25, 2013 | D | $30,000,002 similar: $829,831–$9,999,998 | $30,000,002 | 20 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | PATIENTKEEPER INC | Director | Dec 13, 2012 | D | $1,080,000 similar: $829,831–$9,999,998 | $900,000 | 1 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | GLAUKOS Corp | Director | Oct 3, 2012 | D | $6,000,000 similar: $829,831–$9,999,998 | $6,000,000 | 11 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | GLAUKOS Corp | Director | Aug 10, 2012 | D | $4,500,000 similar: $829,831–$9,999,998 | $4,500,000 | 14 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Frazier Healthcare VII, L.P. group: Frazier Healthcare | Executive Officer Member of the general partner of the Issuer's general partner | Jul 3, 2012 | D | $400,000,000 similar: $155,000–$5,250,000 | $0 | 0 similar: 4–27 | $1,000,000 similar: $1,000–$100,000 |
| EDGAR ↗ | PATIENTKEEPER INC | Director | Jun 21, 2012 | D/A | $6,250,000 similar: $829,831–$9,999,998 | $1,973,215 | 10 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | PATIENTKEEPER INC | Director | Jun 21, 2012 | D | $6,250,000 similar: $829,831–$9,999,998 | $1,973,215 | 10 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Carticept Medical Inc group: Carticept | Director | Jan 17, 2012 | D | $10,000,000 similar: $829,831–$9,999,998 | $9,566,312 | 3 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | PATIENTKEEPER INC | Director | Dec 22, 2011 | D | $3,000,000 similar: $829,831–$9,999,998 | $558,653 | 9 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Moximed, Inc group: Med Tech Arbitrage | Director | Dec 5, 2011 | D/A | $45,862,892 similar: $829,831–$9,999,998 | $45,837,656 | 55 similar: 2–15 | $1 similar: $10,000–$54,310 |
| EDGAR ↗ | PATIENTKEEPER INC | Director | Sep 26, 2011 | D | $3,000,000 similar: $829,831–$9,999,998 | $1,500,000 | 9 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | PIVOT MEDICAL INC | Director | Jul 11, 2011 | D | $5,000,000 similar: $829,831–$9,999,998 | $2,000,000 | 2 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Moximed, Inc group: Med Tech Arbitrage | Director | Jun 7, 2011 | D | $45,300,000 similar: $829,831–$9,999,998 | $43,269,656 | 6 similar: 2–15 | $2 similar: $10,000–$54,310 |
| EDGAR ↗ | GLAUKOS Corp | Director | Feb 1, 2011 | D | $29,500,003 similar: $829,831–$9,999,998 | $29,500,003 | 18 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | PIVOT MEDICAL INC | Director | Dec 21, 2010 | D | $5,000,000 similar: $829,831–$9,999,998 | $2,725,000 | 2 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | GLAUKOS Corp | Director | Sep 23, 2010 | D | $6,000,392 similar: $829,831–$9,999,998 | $6,000,392 | 11 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | NUON THERAPEUTICS INC | Director | Aug 11, 2010 | D | $9,999,999 similar: $2,000,000–$19,999,994 | $9,999,999 | 9 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Achaogen Inc | Director | Apr 19, 2010 | D | $56,413,706 similar: $2,000,000–$19,999,994 | $35,360,873 | 15 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | NUON THERAPEUTICS INC | Director | Mar 17, 2010 | D | $6,125,766 similar: $1,694,259–$16,000,000 | $6,053,189 | 6 similar: 1–13 | $1 similar: $10,000–$55,000 |
| EDGAR ↗ | Carticept Medical Inc group: Carticept | Director | Mar 12, 2010 | D | $20,000,002 similar: $829,831–$9,999,998 | $10,000,001 | 0 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | OCEANA THERAPEUTICS, INC. | Director | May 27, 2009 | D/A | $50,000,001 similar: $1,694,259–$16,000,000 | $3,000,000 | 4 similar: 1–13 | $16,770 similar: $10,000–$55,000 |
Every row is a Form D or D/A on which the issuer listed this name as a related person. Related-person names are matched on first + last name and the address state on the filing; records that share a name but could not be tied together by a second identifier are listed separately below.
"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years (5 industry/exemption sets on this page); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
People and management entities the issuers listed as related persons on the same Form D filings as Robert More. Source: the EDGAR rows in the table above. Showing the 40 with the most shared filings.
None found in sources searched.
Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.
Export this report as PDF (members · included free during the launch period)
No corrections have been requested for this page.
Free. Logged with status: received → under review → fixed / confirmed with source.
If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.
Members get an email when Robert More appears on a new Form D, or when a court case or SEC action is matched to them. See plans →